MetLife Posts Q3 EPS Beat and Generali Boosts Stake by 35%
MetLife reported Q3 EPS of $2.37, beating consensus by $0.07 on revenue of $12.46B, down 5.9% year-over-year. Generali Asset Management increased its MetLife stake by 35% in Q3 to 28,075 shares worth $2.313M.
1. Generali Asset Management Significantly Increases Stake
In its latest SEC filing for the third quarter, Generali Asset Management SPA SGR boosted its MetLife shareholding by 35.0%, adding 7,272 shares and bringing its total position to 28,075 shares valued at approximately $2.31 million. This move underscores growing confidence from a major European asset manager in MetLife’s business model and capital returns. Other institutions followed suit: Quaker Wealth Management LLC more than tripled its position, while Salomon & Ludwin LLC and True Wealth Design LLC nearly doubled and sextupled their holdings, respectively. Hedge funds and institutional investors now collectively own 94.99% of MetLife stock, highlighting the company’s status as a core holding among professional money managers.
2. Analyst Ratings Point to Continued Upside
Wall Street research teams remain broadly positive on MetLife’s outlook. Morgan Stanley and Mizuho both assigned outperform or overweight ratings, emphasizing the company’s strong return on equity and diversified product mix. UBS Group and Wells Fargo & Company also maintain buy or overweight recommendations, even after modest adjustments to their target prices. Of the 13 analysts covering MetLife, 11 carry strong buy or buy ratings, resulting in a consensus buy recommendation. The average analyst target implies mid‐single‐digit upside from current levels, driven by anticipated improvements in underwriting margins and efficiency gains in the retirement and group benefits businesses.
3. Recent Earnings Beat and Sustainable Dividend Profile
MetLife delivered quarterly earnings per share of $2.37, surpassing consensus estimates by $0.07 and marking a year‐over‐year increase from $1.95. Revenue came in at $12.46 billion, reflecting continued resilience in core insurance operations despite modest top‐line headwinds in annuities sales. The company reported a 21.0% return on equity and a net margin of 5.3%, underscoring disciplined risk management. In early December, the board approved a quarterly dividend of $0.5675 per share, equating to an annualized payout of $2.27 and a yield of roughly 2.8%. With a payout ratio below 45%, MetLife retains ample capacity to fund growth initiatives and opportunistic share repurchases.